Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Trinh C. Pham
Observed name:
Trinh C Pham
Institution:
University of Colorado Anschutz
Observed institution:
University of Colorado Anschutz
ORCID:
0009-0006-9305-2011
Observed ORCID:
0009-0006-9305-2011
OpenAlex ID:
A5144356966
Advanced models of lobular breast cancer metastasis capture clinical organ tropism, endocrine response, and bone remodeling
2026
·
Joseph L. Sottnik
, Mary E. Buchanan
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Figure 4 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Data from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Figure 3 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Supplementary Figure 4 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Supplementary Figure 2 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Figure 6 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Supplementary Figure 3 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Supplementary Table 1 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Figure 2 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Figure 5 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Supplementary Figure 1 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Figure 1 from Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
Targeting Wild-type NTRK in NTRK Fusion–Negative Lung Cancer Decreases Brain Metastases
2026
·
Maria J. Contreras-Zárate
, Jenny A. Jaramillo-Gómez
, et al.
·
Cancer Research Communications
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases
2026
·
Morgan S. Fox
, Jenny A. Jaramillo-Gómez
, et al.
·
Nature Communications
Abstract 2076: FGFR1 drives progression of ER+ breast cancer brain metastases in young and aged hosts.
2026
·
Morgan S. Fox
, Jenny A. Jaramillo-Gómez
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type